Clinical Trial

Aqueous Humor Proteome in Retinal Vein Occlusion With Macular Edema

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
the goal of this observational study is to the find the molecular mechanisms underlying the prognosis process of Retinal vein occlusion in patients with retinal vein occlusion . The main question it aims to answer is: What are the changes in protein in the aqueous humor during treatment in patients who are sensitive to anti-VEGF drug therapy?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-30.
Trial Details
NCT Number NCT07106268
Lead Sponsor Tianjin Medical University Eye Hospital
Conditions Retinal Vein Occlusion
Enrollment 100 participants
Start Date 2023-03-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-07